The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells

This publication has 50 references indexed in Scilit:

• Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy
  Seminars in Oncology, 2002
• The Bcl2 family: regulators of the cellular life-or-death switch
  Nature Reviews Cancer, 2002
• Death and anti-death: tumour resistance to apoptosis
  Nature Reviews Cancer, 2002
• Apoptosis: A Link between Cancer Genetics and Chemotherapy
  Published by Elsevier ,2002
• Arsenic Trioxide in Multiple Myeloma
  The Cancer Journal, 2002
• BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis
  Molecular Cell, 2001
• Multiple Myeloma
  Hematology-American Society Hematology Education Program, 2001
• Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins
  Cell, 2000
• Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition
  Cell, 2000
• Molecular characterization of mitochondrial apoptosis-inducing factor
  Nature, 1999